Graham Partners Assembles Medical Molding Group
Investment firm has funded a new conglomerate of three medical injection molders.
Graham Partners, a private investment firm, has helped assemble what it calls “a premium medical-device manufacturing platform of scale” through its portfolio company, Medbio LLC, Grand Rapids, Mich. In 2018, Graham made a substantial investment in Medbio, a contract manufacturer specializing in cleanroom injection molding for medical and biotech customers. The firm has 45 injection presses from 17 to 350 tons.
Medbio cleanroom for medical injection molding. Medbio’s latest acquisition has Class 7 & 8 cleanrooms.
In February 2019, Medbio acquired AIM Plastics, Clinton Township, Mich., an injection molder (30+ presses from 35 to 440 tons) and moldmaker focused primarily on medical markets, with a 6000-ft2 Class 7 cleanroom. Then in September 2020, Medbio added to its growing stable Polymer Conversions, Inc. (PCI), Orchard Park, N.Y., a full-service medical-device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. It has 26 presses of up to 390 tons.
A new class of semi-aromatic, high-temperature nylons is being introduced to the U.S. by Kuraray America in N.Y.C.
Medical tubes are becoming ever smaller and thinner while adding new features like high-tech material combinations, more wire braiding/wrapping, and heat-shrink sheathing for strength and kink resistance.
Next month’s mammoth triennial plastics show in Düsseldorf, Germany, challenges injection molding machine builders to demonstrate technological leadership in addressing the needs of the marketplace.